Home » Psivida Announces Future Out-Licensing of BioSilicon
Psivida Announces Future Out-Licensing of BioSilicon
Global nanotechnology company Psivida has announced it has signed an agreement with U.S.-based PureTech Development to investigate and evaluate out-licensing opportunities for BioSilicon with an emphasis on tissue engineering, wound management and orthopedics.
nanotechwire.com (http://nanotechwire.com/news.asp?nid=1683)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct